Organization · Venture Capital
Nottingham Technology Ventures Ltd
Nottingham Technology Ventures Ltd (NTV) is a subsidiary of the University of Nottingham that manages the university's spin-out portfolio and the Nottingham Invention Fund, focusing on technology commercialization and early-stage development of university research-based companies.
Overview
What Nottingham Technology Ventures Ltd does
What Nottingham Technology Ventures Ltd is
Nottingham Technology Ventures Ltd (NTV) is a subsidiary of the University of Nottingham that manages the university's spin-out portfolio and the Nottingham Invention Fund, focusing on technology commercialization and early-stage development of university research-based companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Nottingham Technology Ventures Ltd elsewhere
Open the official website or a supported primary organization account.
Capability profile
Nottingham Technology Ventures Ltd as a funder
Investment thesis
Nottingham Technology Ventures Ltd (NTV) focuses on transforming University of Nottingham research into commercial ventures by managing spin-out companies and providing early-stage investment through the Nottingham Invention Fund.
Focus narrative
NTV focuses on managing investments in spin-out companies that originate from university research. The organization supports early-stage companies in sectors such as healthcare, materials and manufacturing, agriculture and the environment, and digital technologies, aiming to commercialize research projects with substantial societal impact.
Value beyond capital
NTV adds value to its portfolio companies by providing early-stage capital, governance support, and access to university resources and expertise. The organization helps spin-outs navigate the commercialization process and attract additional investment and specialist knowledge.
Terms and economics
- Typical check
- $60,000–$250,000
- Sweet spot
- $100,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Regions
- United KingdomEurope
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 40
Portfolio context
Notable companies in the NTV portfolio include: Locate Bio: Develops thermally-activated, injectable scaffolds for tissue growth. Exonate: Works on Vascular Endothelial Growth Factors (VEGF) control agents for therapeutics. Oncimmune: Focuses on early cancer diagnosis and management. Added Scientific: Provides consultancy in additive manufacturing. Cerca Magnetics: Develops a wearable magnetoencephalography (MEG) system for brain imaging. NuVision Biotherapies: Raises funds to scale eye treatment technology. Blueskeye AI: Develops AI technology for monitoring mental health conditions.
Common questions
What to know about Nottingham Technology Ventures Ltd
Upseed classifies Nottingham Technology Ventures Ltd under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.